Filtered By:
Source: CardioBrief
This page shows you your search results in order of date.
Order by Relevance | Date
Total 307 results found since Jan 2013.
Should the ACC Have a Live Meeting?
I was surprised to learn from a recent press release that the American College of Cardiology is planning to have some live participants at its annual scientific sessions meeting in May. The college said it is also partnering with a technology company to offer these participants a wearable monitoring device “as an added safety measure...Click here to continue reading...
Source: CardioBrief - January 25, 2021 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics Prevention, Epidemiology & Outcomes American College of Cardiology COVID-19 pandemic Scientific Sessions Source Type: blogs
Cardiology Research: Business As Usual During the Pandemic
At this moment in time the pre-pandemic cardiology research agenda needs to be completely reprioritized. There are two broad areas that now take precedence over all existing research concerns. On the one hand, researchers need to achieve a better understanding of the staggering incidence of deferred or delayed treatment of cardiovascular events and conditions as...Click here to continue reading...
Source: CardioBrief - October 29, 2020 Category: Cardiology Authors: Larry Husten Tags: Epidemiology & Outcomes People, Places & Events Policy & Ethics coronavirus COVID-19 pandemic research agenda Source Type: blogs
A COVID-19 Cardiac MRI Study: What Went Wrong?
We still don’t know what COVID-19 is doing to the heart or how we should be investigating it and treating it. Last month JAMA Cardiology published a German cohort study of 100 patients recently recovered from COVID-19… A number of striking problems with the study were noted on Twitter…...Click here to continue reading...
Source: CardioBrief - August 24, 2020 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics Prevention, Epidemiology & Outcomes COVID-19 MRI scientific misconduct Source Type: blogs
Don ’ t Confuse the Art and Science of Medicine: PCI vs CABG for Left Main Disease
It is often said that medicine is both an art and a science. In an imperfect world this is both inevitable and desirable. But it is extremely important that the two should not be confused with each other. In particular, because the “science” side of the equation has achieved overwhelming prestige and authority, it is...Click here to continue reading...
Source: CardioBrief - August 20, 2020 Category: Cardiology Authors: Larry Husten Tags: Interventional Cardiology & Surgery People, Places & Events Policy & Ethics CABG guidelines left main disease LMCA PCI Source Type: blogs
No, CRISPR Is Not Going To ‘ Cure ’ Heart Disease
No, CRISPR gene editing technology is not going to “cure” heart disease. But a New York Times story by Gina Kolata on an extremely early study in animals prominently plays up just this extremely unlikely claim. The Times story is based on a press release issued by Verve Therapeutics, a new biotechnology company founded by Sekar Kathiresan, an influential cardiologist and genomic...Click here to continue reading...
Source: CardioBrief - June 30, 2020 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics Prevention, Epidemiology & Outcomes CRISPR gene editing hype journalism LDL PCSK9 Source Type: blogs
Cardiovascular Research Foundation Blocks Press Access to TCT2018 Meeting
(Updated) The Cardiovascular Research Foundation (CRF) has denied press credentials for the TCT2018 meeting to a legitimate, fully accredited journalist. The meeting, which starts this weekend in San Diego, is the premiere interventional cardiology meeting. Legitimate journalists are routinely granted access to cover medical and scientific meetings. By any standard, Cat Ferguson is a respected and...Click here to continue reading...
Source: CardioBrief - September 19, 2018 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics CRF journalism TCT meeting TCT2018 Source Type: blogs
Warning: Pirate Sites Are Now Kidnapping Doctors Booking Hotels At Medical Meetings
Pirates are attacking interventional cardiology meetings. Interventional cardiologists planning to attend the upcoming TCT meeting should be aware that at least one pirate web site is out to dupe them. (The annual TCT meeting, which runs this year in San Diego from September 21-25, is the première meeting for interventional cardiologists.) The pirates are trying...Click here to continue reading...
Source: CardioBrief - July 24, 2018 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics fake advertising fraud hotel rooms internet schemes pirate sites TCT TCT meeting Source Type: blogs
1 in 4 Cardiovascular Patients in Low Income Families Have Significant Financial Pain
Editor’s note: The following guest post is by Khurram Nassir, a cardiologist at the Yale University School of Medicine. He is the senior author of a new paper in JAMA Cardiology, “Association of Out-of-Pocket Annual Health Expenditures With Financial Hardship in Low-Income Adults With Atherosclerotic Cardiovascular Disease in the United States.” 1 in 4 Cardiovascular...Click here to continue reading...
Source: CardioBrief - July 4, 2018 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics financial hardship Source Type: blogs
On Cannibals And Cardiologists
Everyone knows that cannibalism was practiced widely in pre-Colombian Mexico. Go online and you will quickly learn that 15,000 to 20,000 Aztecs were sacrificed each year. This “fact” colors our view of that civilization, and makes it a bit easier to give a pass to the conquistadors who, for all their own rapacity, brought “civilization”...Click here to continue reading...
Source: CardioBrief - June 21, 2018 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics ICDs overuse stents Source Type: blogs
New ORBITA Findings May Offer Modest Symptomatic Pain Relief To Interventional Cardiologists
New data presented at EuroPCR from the much debated ORBITA trial may provide some modest temporary lessening of the pain felt by interventional cardiologists in response to the initial negative ORBITA findings. But the pain relief is likely to be only temporary, and might even be fairly compared to a placebo effect, since the major...Click here to continue reading...
Source: CardioBrief - May 22, 2018 Category: Cardiology Authors: Larry Husten Tags: Interventional Cardiology & Surgery People, Places & Events Policy & Ethics ORBITA PCI sham controls stable angina stents Source Type: blogs
More Controversy Over Major Cardiology Clinical Trial
Think about this: A new article reports that a major NIH-funded trial runs into trouble. The article raises all sorts of fundamental questions about our ability to perform meaningful clinical research. But instead of expressing concern about these legitimate problems, medical leaders ignore these questions and instead focus their ire and criticism on the article authors,...Click here to continue reading...
Source: CardioBrief - March 30, 2018 Category: Cardiology Authors: Larry Husten Tags: Interventional Cardiology & Surgery People, Places & Events Policy & Ethics Prevention, Epidemiology & Outcomes clinical trials ischemia NIH PCI primary endpoint revascularization stents Source Type: blogs
Cardiology World Erupts Into Controversy Over Change In Major Clinical Trial
As a major clinical trial in cardiology nears completion it has provoked a storm of criticism and controversy. The brouhaha erupted in response to a late change to one of the most important— and already controversial— trials in cardiovascular medicine. The NIH-funded ISCHEMIA trial was designed back in 2011 to provide a definitive answer to...Click here to continue reading...
Source: CardioBrief - March 18, 2018 Category: Cardiology Authors: Larry Husten Tags: Interventional Cardiology & Surgery People, Places & Events Policy & Ethics Prevention, Epidemiology & Outcomes Uncategorized clinical trials ischemia NIH ORBITA primary endpoint stents Source Type: blogs
More Bad News For The Once Promising Bioresorbable Stent
(Updated) –Problems for the Absorb BVS stent just won’t disappear Bad news for the Absorb BVS stent continues to accumulate, though defenders of the device keep looking for a silver lining. When it was approved in the US last summer the novel device appeared to have a bright future, with many prominent interventional cardiologists predicting...Click here to continue reading...
Source: CardioBrief - March 31, 2017 Category: Cardiology Authors: Larry Husten Tags: Interventional Cardiology & Surgery People, Places & Events Policy & Ethics Abbott ABSORB bioresorbable stent BVS DAPT stent throb Source Type: blogs
Interventional Cardiologists Face Major Obstruction In Treatment Of Total Blockages
–Deep divisions over how CTO patients should be treated. In recent years ambitious interventional cardiologists have started to perform PCI on chronic total occlusions (CTOs), though these lesions have long been recognized as among the most difficult to successfully treat. Many other physicians, including some prominent interventional cardiologists, have expressed grave concerns about this expansion...Click here to continue reading...
Source: CardioBrief - March 29, 2017 Category: Cardiology Authors: Larry Husten Tags: Interventional Cardiology & Surgery People, Places & Events Policy & Ethics chronic total occlusion CTO Source Type: blogs
Novel Drug Delivers Long Term Cholesterol Reduction
A novel drug that dramatically lowers LDL cholesterol and needs to be administered only a few times a year has reached a new milestone. Positive results from a phase II study with the drug, now known as inclisiran, were reported at the American College of Cardiology meeting in Washington, DC and published simultaneously in the...Click here to continue reading...
Source: CardioBrief - March 17, 2017 Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Prevention, Epidemiology & Outcomes cholesterol inclisiran LDL Medicines Company PCSK9 Source Type: blogs
